All stock lists
COMMERZBANK Aktiengesellschaft (Deutsche Börse:CBK.DE)
DE · Delayed Price · Currency is EUR
Also listed: CRZBFFinancial Services · Banks - Regional
37.18+0.91 (+2.51%)
Market cap
$40.2B
Health Score
Analyst consensus
Listed since
Dec 16, 1996
Website
Insider Score
––Not scored
CBK.DE Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Sound
From CBK.DE’s reported statements · Q2 2026 (trailing 12 months)
Profitability18 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $20.57B
- Net income
- $3.14B
- Net margin
- 15.3%
Leverage20 / 20
Little or no net debt.
- Total debt
- $3.51B
- Cash
- $58.96B
- Net debt / EBITDA
- -11.54x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $58.96B
- Current liabilities
- $474.91B
- Current ratio
- 0.12
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $0
- Free cash flow
- $0
- FCF margin
- 0.0%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 1080.8M
- Share growth (1y)
- -4.1%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CBK.DE Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 6.18 B | 6.05 B | 3.06 B | 5.28 B | 6.27 B | 5.87 B |
| Revenue Growth (YoY) | -1.47 % | 3.03 % | -57.17 % | -2.40 % | -6.97 % | -1.26 % |
| Cost of Revenue | 2.86 B | 2.74 B | 207.00 M | 2.79 B | 2.81 B | 2.81 B |
| Gross Profit | 3.31 B | 3.31 B | 2.85 B | 2.50 B | 3.46 B | 3.06 B |
| SG&A Expense | 0.00 | 0.00 | 0.00 | 0.00 | 1.65 B | 0.00 |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.95 B | 1.95 B | 1.80 B | 1.47 B | 2.78 B | 1.88 B |
| Operating Income | 1.37 B | 1.36 B | 1.06 B | 1.03 B | 675.00 M | 1.19 B |
| Pretax Income | 1.36 B | 1.36 B | 1.06 B | 1.03 B | 675.00 M | 1.19 B |
| Tax Provision | 389.00 M | 373.00 M | 259.00 M | 374.00 M | 150.00 M | 306.00 M |
| Net Income | 897.00 M | 913.00 M | 737.00 M | 592.00 M | 462.00 M | 834.00 M |
| EPS (Basic) | 0.83 | 0.81 | 0.65 | 0.52 | 0.15 | 0.73 |
| EPS (Diluted) | 0.83 | 0.81 | 0.65 | 0.52 | 0.15 | 0.73 |
| Shares Outstanding | 1.08 B | 1.13 B | 1.13 B | 1.13 B | 1.13 B | 1.14 B |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.